Hemoglobin A1c: Assessment of three POC analyzers relative to a central laboratory method

Clinica Chimica Acta

Volumn 411, Issue 23-24, 2010, Pages 2062-2066

  Petersen, John R ^a   Omoruyi, Felix O ^b   Mohammad, Amin A ^c   Shea, Thomas J ^a   Okorodudu, Anthony O ^a   Ju, Hyunsu ^a  

^a UNIVERSITY OF TEXAS MEDICAL BRANCH   (United States)

^b TEXAS A AND M UNIVERSITY CORPUS CHRISTI   (United States)

^c SCOTT AND WHITE MEMORIAL HOSPITAL   (United States)

Author keywords

HbA1c; Hemoglobin A1c; POCT; Point of care testing

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C;

ANALYTICAL ERROR; ARTICLE; AUTOANALYZER; CONTROLLED STUDY; GLUCOSE BLOOD LEVEL; HEALTH CARE NEED; HEALTH EDUCATION; HEMOLYSIS; INSTRUMENT VALIDATION; INTERMETHOD COMPARISON; LABORATORY TEST; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; REFERENCE VALUE;

ANALYSIS OF VARIANCE; BLOOD CHEMICAL ANALYSIS; HEMOGLOBIN A, GLYCOSYLATED; HUMANS; LABORATORIES; POINT-OF-CARE SYSTEMS; REFERENCE STANDARDS; TIME FACTORS;

EID: 77957749916     PISSN: 00098981     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cca.2010.09.004     Document Type: Article

References (16)

1. Sacks D.B., Bruns D.E., Goldstein D.E., Maclaren N.K., McDonald J.M., Parrott M. Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus. Clin Chem 2002, 48:436-472.
2. American Diabetes Association Standards of medical care in diabetes - 2009. Diab Care 2009, 32(Suppl 1):S13-S62.
3. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med 1993, 329:977-986. The Diabetes Control and Complications Trial Research Group.
4. Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). Lancet 1998, 352:837-853. UK Prospective Diabetes Study (UKPDS) Group.
5. Cagliero E., Levina E., Nathan D. Immediate feedback of HbA1c levels improves glycemic control in type 1 and insulin-treated type 2 diabetic patients. Diab Care 1999, 22:1785-1789.
6. Ferenczi A., Reddy K., Lorber D.L. Effect of immediate hemoglobin A1c results on treatment decisions in office practice. Endocr Pract 2001, 7:85-88.
7. Miller C.D., Barnes C.S., Phillips L.S., et al. Rapid A1c availability improves clinical decision-making in an urban primary care clinic. Diab Care 2003, 26:1158-1163.
8. Petersen J.R., Finley J.B., Okorodudu A.O., Mohammad A.A., Bajaj M. Effect of point of care on the maintenance of glycemic control as measured by hemoglobin a1c. Diab Care 2007, 30:713-715.
9. 1c: a cause for concern?. Am J Clin Pathol 2008, 129:540-547.
10. Nathan D.M., Kuenen J., Borg R., Zheng H., Schoenfeld D., Heine R.J. Translating the A1C assay into estimated average glucose values. Diab Care 2008, 31:1473-1478.
11. Mosca A., Goodall I., Hoshino T., et al. Global standardization of glycated hemoglobin measurement: the position of the IFCC working group. Clin Chem Lab Med 2007, 45:1077-1080.
12. Holmes E.W., Charnogursky G.A. Point-of-care testing for measuring hemoglobin A1c: is it really worthwhile - Author reply. Am J Clin Pathol 2008, 130:646-647.
13. White G.H., Farrance I. Uncertainty of measurement in quantitative medical testing - a laboratory implementation guide. Clin Biochem Rev 2004, 25:S1-S23. (suppl).
14. Shephard M.D.S. Analytical goals for POCT used for diabetes management in Australian health care settings outside the laboratory. Point Care 2006, 5:177-185.
15. 1c assay methods meet clinical needs. Clin Chem 2010, 56:4-6.
16. 1c point-of-care instruments do not meet the general accepted analytical performance criteria. Clin Chem 2010, 57:44-52.